Search

Home > GRACEcast Lung Cancer Video > RET in Lung Cancer: The Next Big Target?
Podcast: GRACEcast Lung Cancer Video
Episode:

RET in Lung Cancer: The Next Big Target?
Category: Science & Medicine
Duration: 00:03:32
Publish Date: 2015-07-07 14:00:00
Description:

A trial studying Cometriq (cabozantinib) for RET rearrangements showed a promising response rate, which led the doctors to discuss if they think RET is going to be the next actionable target in lung cancer.
Total Play: 0